SMS Lifesciences India Limited (Security Code: 540679, Symbol: SMSLIFE) has announced that it has carried out a preliminary analysis of Ranitidine product and processes and found that the NDMA impurity is in trace levels, in many cases lower than the levels found in commonly consumed food, milk, meat etc. While it continues to investigate the root cause and establish controls to ensure the product safety and stability. It is awaiting further directives from Central Drugs Standard Control Organization (CDSCO), regulatory agency to review and establish acceptable limits for NDMA (N-Nitrosodimethylamine) impurity in Ranitidine.
As regulatory guidance is awaited for limits of NDMA, the company sees a temporary slow-down in sales of Ranitidine which is one of the major contributor of revenues. The company anticipates business as usual in future as it is confident of providing a safe and stable Ranitidine product to all its customers, with NDMA impurity well within acceptable limits set by the Drug regulator, authorities.
Shares of SMS Lifesciences India Ltd was last trading in BSE at Rs.286.1 as compared to the previous close of Rs. 298.8. The total number of shares traded during the day was 407 in over 27 trades.
The stock hit an intraday high of Rs. 300 and intraday low of 285.7. The net turnover during the day was Rs. 118630.